Evaluation of thrombospondin 1 as a novel biomarker in pediatric-onset systemic lupus erythematosus
In light of the current data, the efficacy of TBS-1 as a biomarker in pSLE diverged from its performance in adult SLE. In summary, TBS-1 shows potential as a biomarker for pSLE, particularly in hematological manifestations. Further investigations are essential to delve into the immunomodulatory roles of TBS-1 in the autoimmune pathways of pSLE.
Authors
- Menglan Zhang
- Yongmei Jiang (ORCID: https://orcid.org/0000-0002-0487-1888)
- Lingyi Yan
- Chenxi Liu (ORCID: https://orcid.org/0000-0002-1208-1309)
- Zhijun Liu (ORCID: https://orcid.org/0000-0002-8215-9271)
- Jie Luo
- Ting Liu (ORCID: https://orcid.org/0009-0001-8018-1037)
Institutions
- Sichuan University (CN)
- West China Second University Hospital of Sichuan University (CN)
Publication Details
- Journal
- BMC Pediatrics
- Published
- 2025-03-13
- DOI
- https://doi.org/10.1186/s12887-025-05542-7
- Citations
- 1
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 1.67